| |
| Issue |
Title |
| |
| Online First |
Human hepatitis B immunoglobulins: Standardisation issues |
Abstract
PDF (Rus)
|
|
E. A. Konovalova, E. N. Kalinina, E. S. Kormshchikova, E. V. Rosina, S. E. Ziganshina, K. A. Vorobiev, I. V. Paramonov |
| |
| Online First |
Implementation of the quality-by-design concept for an adeno-associated viral vector-based gene therapy |
Abstract
PDF (Rus)
|
|
D. S. Kopein, G. N. Poroshin, R. A. Khamitov |
| |
| Vol 23, No 4 (2023) |
International standards for monoclonal antibodies for assessing the biological activity of medicines: A status update |
Abstract
PDF (Rus)
|
|
L. A. Gayderova, N. A. Alpatova, S. L. Lysikova, M. L. Baykova, A. M. Guskov, D. A. Zubkov |
| |
| Vol 23, No 4 (2023) |
Results and prospects of rotavirus immunisation in the Russian Federation |
Abstract
PDF (Rus)
|
|
A. S. Korovkin, G. M. Ignatyev |
| |
| Vol 23, No 4 (2023) |
Current regulatory requirements for clinical trials of viral vaccines |
Abstract
PDF (Rus)
|
|
A. A. Soldatov, D. V. Gorenkov, Zh. I. Avdeeva, V. A. Merkulov |
| |
| Vol 23, No 3 (2023) |
Current trends and risks associated with the use of therapies based on genome editing |
Abstract
PDF (Rus)
|
|
O. A. Rachinskaya, E. V. Melnikova, V. A. Merkulov |
| |
| Vol 23, No 3 (2023) |
Botulinum toxin preparations: areas for improvement and issues of standardisation |
Abstract
PDF (Rus)
|
|
M. V. Savkina, M. A. Krivykh, L. V. Sayapina, Yu. I. Obukhov, V. P. Bondarev |
| |
| Vol 22, No 3 (2022) |
Promising directions for vaccine development to prevent shigellosis |
Abstract
PDF (Rus)
|
|
M. V. Abramtseva, E. O. Nemanova, N. S. Alekhina |
| |
| Vol 22, No 3 (2022) |
Human anti-D immunoglobulin preparations: potency standardisation milestones |
Abstract
PDF (Rus)
|
|
N. S. Vildanova, E. S. Kormshchikova, E. N. Kalinina, K. A. Vorobiev, I. V. Paramonov, E. Yu. Kudasheva |
| |
| Vol 22, No 3 (2022) |
Procedure for preparation, certification, and storage of a seed lot of the Mycobacterium bovis BCG-I (Russia) vaccine strain |
Abstract
PDF (Rus)
|
|
D. T. Levi, R. I. Ludannyy, Yu. I. Obukhov, A. A. Savina, A. A. Alesina, N. V. Aleksandrova |
| |
| Vol 22, No 2 (2022) |
Promising opportunities to improve polio vaccines |
Abstract
PDF (Rus)
|
|
E. E. Evreinova, L. M. Khantimirova, V. A. Shevtsov, V. A. Merkulov, V. P. Bondarev |
| |
| Vol 22, No 2 (2022) |
Prospects for ion chromatography in quality assessment of biologicals |
Abstract
PDF (Rus)
|
|
A. S. Minero, O. B. Runova, O. B. Ustinnikova, A. A. Movsesyants |
| |
| Vol 22, No 2 (2022) |
Minimisation of the viral contamination risk of heterologous immunoglobulins in the context of the requirements of the State Pharmacopoeia of the Russian Federation |
Abstract
PDF (Rus)
|
|
V. V. Mashin, A. N. Sergeev, N. N. Martynova, T. V. Antipina, E. I. Sakanyan, V. V. Kataeva, N. V. Zagidullin |
| |
| Vol 22, No 2 (2022) |
Analysis of pneumococcal serotypes distribution to determine a model composition for a Russian pneumococcal conjugate vaccine |
Abstract
PDF (Rus)
|
|
V. P. Trukhin, A. E. Evtushenko, E. L. Salimova, A. D. Konon, M. R. Khaitov, V. A. Merkulov |
| |
| Vol 22, No 1 (2022) |
Challenges in development and authorisation of gene therapy products |
Abstract
PDF (Rus)
|
|
A. A. Soldatov, Zh. I. Avdeeva, D. V. Gorenkov, L. M. Khantimirova, S. G. Guseva, V. A. Merkulov |
| |
| Vol 21, No 4 (2021) |
Review of global use of licensed vaccines and development of new vaccines for the prevention of pneumococcal infection |
Abstract
PDF (Rus)
|
|
M. V. Savkina, M. A. Krivykh, N. A. Gavrilova, L. V. Sayapina, Yu. I. Obukhov, V. A. Merkulov, V. P. Bondarev |
| |
| Vol 21, No 4 (2021) |
Comparative analysis of existing platforms for the development of vaccines against dangerous and extremely dangerous viral infections with pandemic potential |
Abstract
PDF (Rus)
|
|
G. G. Onishchenko, T. E. Sizikova, V. N. Lebedev, S. V. Borisevich |
| |
| Vol 21, No 4 (2021) |
Production of solid dosage forms of immunoglobulin products |
Abstract
PDF (Rus)
|
|
E. G. Abramova, A. V. Komissarov, N. V. Sinitsyna, I. M. Zhulidov, A. K. Nikiforov |
| |
| Vol 21, No 4 (2021) |
Approaches to quality control, preclinical and clinical studies of live recombinant viral vector vaccines |
Abstract
PDF (Rus)
|
|
L. M. Khantimirova, D. V. Gorenkov, S. G. Guseva, V. A. Merkulov, A. A. Soldatov |
| |
| Vol 21, No 3 (2021) |
Comparative characteristics of COVID-19 vaccines used for mass immunisation |
Abstract
PDF (Rus)
|
|
G. G. Onishchenko, T. E. Sizikova, V. N. Lebedev, S. V. Borisevich |
| |
| Vol 21, No 3 (2021) |
Vaccine interchangeability: problems and prospects |
Abstract
PDF (Rus)
|
|
N. A. Gavrilova, Yu. V. Olefir, V. A. Merkulov, V. P. Bondarev, E. M. Rychikhina, Yu. I. Obukhov |
| |
| Vol 21, No 3 (2021) |
World practice of providing scientific advice on the development and authorisation of innovative medicines |
Abstract
PDF (Rus)
|
|
E. V. Melnikova, O. V. Merkulova, V. A. Merkulov |
| |
| Vol 21, No 2 (2021) |
In vitro methods for rabies virus detection, and evaluation of their use in the production of rabies immunoglobulin |
Abstract
PDF (Rus)
|
|
Yu. K. Gavrilova, S. V. Generalov, E. G. Abramova, A. K. Nikiforov |
| |
| Vol 21, No 2 (2021) |
Typhoid vaccines. Historical aspects of typhoid vaccine development, and currently available products |
Abstract
PDF (Rus)
|
|
M. V. Abramtseva, E. O. Nemanova, N. S. Alekhina, T. I. Nemirovskaya |
| |
| Vol 21, No 2 (2021) |
Factor VIII products: key aspects of development, clinical research and use (part 2) |
Abstract
PDF (Rus)
|
|
Zh. I. Avdeeva, A. A. Soldatov, V. P. Bondarev, V. D. Mosyagin, V. A. Merkulov |
| |
| Vol 21, No 1 (2021) |
Factor VIII products: key aspects of development, clinical research and use (part 1) |
Abstract
PDF (Rus)
|
|
Zh. I. Avdeeva, A. A. Soldatov, V. P. Bondarev, V. D. Mosyagin, V. A. Merkulov |
| |
| Vol 21, No 1 (2021) |
General characteristics of adjuvants and their mechanisms of action (part 2) |
Abstract
PDF (Rus)
|
|
N. А. Alpatova, Zh. I. Avdeeva, S. L. Lysikova, O. V. Golovinskaya, L. A. Gayderova, V. P. Bondarev |
| |
| Vol 21, No 1 (2021) |
Pertussis vaccines and the role of Bordetella pertussis lipooligosaccharide in the immune response to pertussis infection and vaccination |
Abstract
PDF (Rus)
|
|
I. A. Alekseeva, O. V. Perelygina, E. D. Kolyshkina |
| |
| Vol 21, No 1 (2021) |
Current incidence of certain clostridial infections: gas gangrene and tetanus |
Abstract
PDF (Rus)
|
|
E. I. Komarovskaya, O. V. Perelygina |
| |
| Vol 20, No 4 (2020) |
Russian and International Regulatory Recommendations for the Development and Marketing Authorisation of COVID-19 Vaccines in the Context of the Pandemic |
Abstract
PDF (Rus)
|
|
A. A. Soldatov, Zh. I. Avdeeva, V. P. Bondarev, V. A. Merkulov, V. D. Mosyagin, V. B. Ivanov, D. V. Gorenkov, L. M. Khantimirova |
| |
| Vol 20, No 4 (2020) |
Analysis of Promising Approaches to COVID-19 Vaccine Development |
Abstract
PDF (Rus)
|
|
G. G. Onishchenko, T. E. Sizikova, V. N. Lebedev, S. V. Borisevich |
| |
| Vol 20, No 4 (2020) |
General Characteristics of Adjuvants and Their Mechanism of Action (Part 1) |
Abstract
PDF (Rus)
|
|
N. A. Alpatova, Zh. I. Avdeeva, S. L. Lysikova, O. V. Golovinskaya, L. A. Gayderova |
| |
| Vol 20, No 3 (2020) |
Prospects for Using the ELISPOT Technological Platform as Part of Anti-Epidemic Measures Against the New Coronavirus Infection COVID-19 |
Abstract
PDF (Rus)
|
|
D. A. Poteryaev, R. A. Khamitov, G. A. Efimov, A. M. Shuster |
| |
| Vol 20, No 3 (2020) |
Comparison of the World Pharmacopoeias’ Requirements for the Quality of Cell Lines |
Abstract
PDF (Rus)
|
|
M. A. Vodyakova, A. R. Sayfutdinova, E. V. Melnikova, Yu. V. Olefir |
| |
| Vol 20, No 3 (2020) |
Effectiveness of Specific Prevention of Tick-Borne Encephalitis |
Abstract
PDF (Rus)
|
|
M. S. Shcherbinina, O. A. Barkhaleva, O. S. Dorokhova, A. A. Movsesyants |
| |
| Vol 20, No 2 (2020) |
Madariaga Virus |
Abstract
PDF (Rus)
|
|
T. E. Sizikova, V. N. Lebedev, S. V. Borisevich |
| |
| Vol 20, No 2 (2020) |
No ntuberculous Mycobacteria |
Abstract
PDF (Rus)
|
|
M. V. Makarova, L. D. Guntupova |
| |
| Vol 20, No 2 (2020) |
Bioethical Aspects of Improving the Production of Rabies Immunoglobulin in Russia |
Abstract
PDF (Rus)
|
|
S. V. Generalov, E. G. Abramova, Yu. K. Gavrilova |
| |
| Vol 20, No 2 (2020) |
Current Trends in the Use of Cell Therapy in Regenerative Medicine |
Abstract
PDF (Rus)
|
|
A. A. Chaplenko, M. D. Khorolsky, E. V. Melnikova, V. A. Merkulov |
| |
| Vol 20, No 1 (2020) |
An Outbreak of a New Infectious Disease COVID-19: β-coronaviruses as a Threat to Global Healthcare |
Abstract
PDF (Rus)
|
|
D. V. Gorenkov, L. M. Khantimirova, V. A. Shevtsov, A. V. Rukavishnikov, V. A. Merkulov, Yu. V. Olefir |
| |
| Vol 20, No 1 (2020) |
General Considerations on Clinical Trials of Hemophilia Medicines |
Abstract
PDF (Rus)
|
|
Zh. I. Avdeeva, A. A. Soldatov, V. P. Bondarev, V. A. Merkulov |
| |
| Vol 20, No 1 (2020) |
Immune Response Induced by Immunisation with Antiviral Vaccines |
Abstract
PDF (Rus)
|
|
N. A. Alpatova, Zh. I. Avdeeva, L. A. Gayderova, S. L. Lysikova, N. V. Medunitsyn |
| |
| Vol 19, No 4 (2019) |
Treatment of Genetic Diseases: Current Trends in the Development of Biomedical Cell Products |
Abstract
PDF (Rus)
|
|
O. A. Rachinskaya, M. A. Vodyakova, E. V. Melnikova, V. A. Merkulov |
| |
| Vol 19, No 4 (2019) |
Elaboration of Pharmacopoeial Quality Standards for Bacteriophage Products |
Abstract
PDF (Rus)
|
|
T. M. Kargina, E. I. Sakanyan, D. S. Davydov, R. L. Parfenyuk |
| |
| Vol 19, No 4 (2019) |
The Current Use of Biomedical Cell Products for Cancer Treatment |
Abstract
PDF (Rus)
|
|
E. A. Ustyugova, M. V. Savkina, A. A. Goryaev, V. P. Bondarev, V. A. Merkulov, E. V. Melnikova |
| |
| Vol 19, No 4 (2019) |
Vaccine Safety and Efficacy in Preventing Rotavirus Infection |
Abstract
PDF (Rus)
|
|
V. A. Shevtsov, E. E. Evreinova, I. N. Indikova, L. M. Khantimirova, D. V. Gorenkov, A. V. Rukavishnikov |
| |
| Vol 19, No 3 (2019) |
Ways to Improve Quality Control of Culture Medium Used for Mycoplasma Detection |
Abstract
PDF (Rus)
|
|
S. M. Sukhanova, Z. E. Berdnikova, A. S. Tikhonova |
| |
| Vol 19, No 3 (2019) |
Culture Media in Pharmacopoeial Analysis: Use, Current Requirements, Standardisation |
Abstract
PDF (Rus)
|
|
S. M. Sukhanova, N. E. Zakharova |
| |
| Vol 19, No 3 (2019) |
Analysis of Measles Incidence in Russia and Problems of Measles Prevention at the Elimination Stage |
Abstract
PDF (Rus)
|
|
T. N. Yunasova, D. V. Gorenkov, A. V. Rukavishnikov, A. A. Movsesyants, V. A. Merkulov |
| |
| Vol 19, No 3 (2019) |
Special Considerations on the Use of Vaccines for Immunoprophylaxis of Bacterial Infections |
Abstract
PDF (Rus)
|
|
N. A. Gavrilova, Е. А. Ustyugova, N. F. Nikityuk, Yu. I. Obukhov, V. P. Bondarev |
| |
| 1 - 50 of 120 Items |
1 2 3 > >>
|
